FABP7 and myeloid sarcoma: Pooling the two control groups resulted in significantly higher responses in MS; adjusted P = 0.0272 for FABP7 pooled, compared to 0.039 and 0.079 for HC and OND independently, and adjusted P = 0.035 for SNAP91 pooled, compared to 0.112 and 0.035 for HC and OND.